GenMark Diagnostics, Inc. elected Stephen Worland, Ph.D. as director to serve a three-year term expiring at GenMark's 2016 Annual Meeting of Stockholders.
GenMark Diagnostics, Inc.
Equities
GNMK
US3723091043
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+7.68% | 217B | |
+14.91% | 195B | |
+30.91% | 112B | |
+3.76% | 65.83B | |
+14.30% | 52.67B | |
+4.70% | 49.86B | |
-4.51% | 38.18B | |
-0.40% | 35.39B | |
+23.86% | 31.02B |